Leonard L. Mazur

Filings by Leonard L. Mazur span 3 companies, the busiest being Citius Pharmaceuticals, Inc., Citius Oncology, Inc. and Canton Strategic Holdings, Inc. Over a trading history stretching from 29 March 2018 to 19 September 2025, the count stands at 8 filings.

Purchases make up the whole of the open-market record (4 purchases, €7.4M). Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants.

In size, the median ticket on the buying side is €1.7M.

The newest entry dates from 22 December 2025: a share grant, in Citius Oncology, Inc. The clock since the last published purchase (27 September 2019) now reads 2,583 days. The median gap between a trade and its publication by SEC (Form 4) is 4 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.